How do you decide if a full-time CRO is right for a PE-backed company when RevOps exists but no revenue leader?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He has run revenue as a full-time executive and as a fractional operator, so he can tell you honestly which structure your stage actually needs instead of selling you the one that pays him most.

👉 See Kory White on LinkedIn

The PE-Backed Buying Committee: Who Decides and How Budget Moves

In a PE-backed company, the buying committee is not just the prospect's procurement team - it includes the PE fund's operating partners, the portfolio company's board (often PE-appointed), and the CFO who reports directly to the fund. The typical deal size ranges from $50,000 to $500,000 in annual contract value for B2B SaaS or tech-enabled services, but the shape is heavily influenced by the fund's thesis: a buy-and-build strategy might push for smaller, faster deals to consolidate market share, while a growth-equity play demands larger, multi-year enterprise agreements that justify a multiple expansion. Budget approval is rarely a single executive decision; it flows through a "value assurance" process where the PE-backed buyer must justify the investment to their own board, which is pressured to show IRR improvements within a 5-7 year hold period. The buyer evaluates not just product fit but the vendor's financial health, because a PE-owned company cannot afford to bet on a supplier that might itself need a recapitalization mid-contract. Deals stall most often at the "internal champion validation" stage, where the prospect's CFO or COO, who is used to PE-level scrutiny, demands a detailed ROI model tied to their own EBITDA targets, and the seller's RevOps team lacks the executive authority to negotiate commercial terms that align with both parties' financial engineering. Without a CRO, the RevOps team can produce the data but cannot close the strategic gap - they cannot sit across from a PE-backed CFO and discuss how the vendor's pricing model maps to the buyer's debt covenant calculations.

Sales Cycle Implications: The Motion, Ramp, and Pipeline Shape

The sales cycle in a PE-backed company is compressed compared to VC-backed peers, because the fund's timeline forces a "grow or exit" urgency that trickles down to every deal. The motion is a hybrid of enterprise consultative selling and transactional velocity: the CRO must orchestrate a process where RevOps handles qualification scoring, lead routing, and forecasting, but the executive must personally close the top 10% of accounts that represent 60% of the pipeline value. Ramp time for a new full-time CRO is typically 90 days to understand the PE fund's reporting cadence and 180 days to reshape the pipeline toward the fund's target exit metrics, but this is slower than a fractional leader who can plug in immediately - which creates a tension: the PE board wants immediate pipeline acceleration, but a full-time hire takes time to onboard and learn the portfolio's unique financial language. The pipeline shape is distorted by the PE ownership: there is often a "bow wave" of high-value deals that were stalled because the prior founder or fractional leader lacked the authority to offer multi-year commitments or pricing flexibility, and these deals sit in late-stage but require a CRO to unblock. The leaks are not at the top of funnel (RevOps can generate leads) but at the "commercial close" stage - specifically, where the prospect's legal or procurement team demands indemnification clauses, SLA penalties, or payment terms that the RevOps team cannot approve without executive sign-off. The forecast behavior is also unique: the PE-backed board expects weekly pipeline reviews with a "committed" category that is legally binding, not optimistic, and a full-time CRO must own the accuracy of that forecast to avoid triggering a fund-level escalation. Without a CRO, the RevOps team can build the forecast model but cannot defend it in a board meeting where the PE operating partner asks, "Why is this deal at 90% probability when the champion hasn't returned a signed MSA?"

What a Fractional, Interim, and Full-Time Revenue Leader Looks Like Here

For a PE-backed company with RevOps but no revenue leader, the first 90 days of any revenue executive must be hyper-specific to the fund's governance. A fractional CRO is often a retired or between-roles executive who works 10-20 hours per week, focused on coaching the RevOps team on pipeline hygiene and closing a few immediate deals, but they lack the bandwidth to attend weekly board calls or negotiate with the fund's legal team on complex contract structures. An interim CRO is a full-time but temporary hire, typically used when the PE fund is preparing for an exit within 12 months and needs someone to "dress the revenue engine" for due diligence - they own the entire revenue function but are not expected to build long-term culture or hire a permanent team. A full-time CRO is right only when the company has reached $10M-$30M in ARR (depending on the fund's thesis) and the RevOps team has proven it can execute operational tasks but cannot set strategy, manage channel partners, or represent the company in fund-level portfolio reviews. The operating cadence for a full-time CRO in a PE-backed company is weekly 1:1s with the fund's operating partner, monthly board reporting with a standard PE dashboard (ARR, churn, LTV/CAC, net dollar retention, pipeline coverage ratio), and quarterly strategic planning tied to the fund's exit timeline. What they own vs advise: they own the revenue forecast, the pricing strategy, the compensation plan for the sales team, and the relationship with the fund's M&A team if the company is doing add-on acquisitions; they advise on product roadmap (but do not own it), marketing spend allocation (but RevOps executes), and channel partner contracts (but legal reviews). The signals to convert from fractional or interim to full-time are: (1) the RevOps team begins to request strategic direction faster than a part-time leader can provide, (2) the fund requires a dedicated executive for a potential IPO or sale within 18 months, and (3) the company's deal complexity has increased to the point where every major contract requires a CRO-level commercial negotiation that a fractional leader cannot attend because they are serving other clients. The counter-signal to avoid a full-time hire is when the RevOps team is still building basic infrastructure (CRM hygiene, lead scoring, forecast accuracy) and a CRO would be underutilized - in that case, a fractional leader who can mentor the RevOps team for 6-12 months is more capital-efficient for the PE portfolio.

The PE Fund's Role in the CRO Decision

The PE fund is not a passive investor; it is the de facto board and often the real decision-maker on whether to hire a full-time CRO. The fund's operating partners evaluate the portfolio company's revenue maturity using a simple heuristic: if the company has hit a "revenue plateau" where ARR growth has flattened despite increased sales headcount, and RevOps can diagnose the problem but cannot fix it (e.g., they know the sales team is not following the process but cannot fire underperformers), then a full-time CRO is warranted. The fund also considers the cost: a full-time CRO at a PE-backed company typically demands a base salary of $250,000-$400,000 plus equity or carry in the portfolio, which is a significant fixed cost that must be justified against the fund's target IRR. The fund will often force a "try before you buy" approach - they mandate a 3-month fractional engagement with a specific mandate (e.g., "fix the sales compensation plan" or "close the top 5 stalled deals") and if the fractional leader achieves the mandate, they are offered a full-time role. This is not standard in VC-backed companies, where a founder often hires a CRO based on intuition; in PE, the decision is data-driven and tied to a specific milestone, such as "when ARR exceeds $15M" or "when the sales team exceeds 10 reps." The fund also evaluates whether the company's RevOps leader is a potential CRO candidate: if the RevOps head has strong strategic instincts and the fund trusts them, they may promote internally and hire a senior RevOps manager to backfill, which avoids the cultural disruption of an external hire. However, this is rare because most RevOps leaders in PE-backed companies are operators, not strategists - they can build the engine but cannot drive it.

The First 90 Days of a Full-Time CRO in a PE-Backed Company

The first 90 days are not about "listening tours" or "team building" - they are about delivering a specific, measurable outcome that the fund can track. Day 1-30: The CRO must audit the existing RevOps infrastructure (CRM data quality, pipeline stages, forecast accuracy, compensation plans) and identify the "revenue leaks" that are costing the fund money - typically, these are deals that are stuck in legal, pricing that is too low because the founder gave discounts, or a sales team that is not following the RevOps-defined process because there was no one to enforce it. The CRO must also meet with the fund's operating partner to understand the exit timeline and the specific revenue metrics that will be used to value the company at exit (e.g., if the fund targets a 5x multiple on ARR, the CRO must know that and align the pipeline accordingly). Day 31-60: The CRO must make changes that are visible to the board: implement a new forecasting methodology (e.g., MEDDIC or MEDDPICC), restructure the sales compensation plan to align with the fund's growth targets, and personally close at least one major deal that was previously stuck. This is critical because the PE board has a short attention span - if the CRO has not produced a tangible revenue win by day 60, the fund will question the hire. Day 61-90: The CRO must build a 12-month revenue plan that is tied to the fund's hold period, including a hiring plan for the sales team, a channel partner strategy, and a pricing optimization initiative that increases average deal size by 10-20% without losing volume. The CRO must also establish a weekly operating rhythm with RevOps: Monday pipeline review, Wednesday deal desk, Friday forecast call - and the RevOps team is expected to produce the data, but the CRO owns the narrative for the board.

The Signals to Convert from Fractional to Full-Time

The decision to convert a fractional or interim revenue leader to full-time is not about "fit" or "culture" - it is about whether the company has reached a scale where the cost of a full-time executive is offset by the revenue acceleration they can deliver. The first signal is when the fractional leader is spending more than 30 hours per week on the company, which indicates that the role has outgrown the part-time model. The second signal is when the RevOps team begins to request strategic guidance that the fractional leader cannot provide because they are not immersed in the company's daily operations - for example, the RevOps team needs a decision on whether to invest in a new CRM tool or hire a sales enablement manager, and the fractional leader does not have the context to make that call. The third signal is when the fund's board meetings require a consistent revenue narrative that a fractional leader cannot maintain because they are juggling multiple clients - the board wants the same face every month who can speak to the pipeline with conviction. The fourth signal is when the company's deal size has increased to the point where every major contract requires a CRO-level commercial negotiation, and the fractional leader's availability is unpredictable. The counter-signal to stay fractional is when the company is still in "build mode" - for example, if the RevOps team is still cleaning up the CRM, defining lead scoring, or building the first forecast model, a full-time CRO will be bored and expensive, and a fractional leader who can mentor the RevOps team is more cost-effective. In a PE-backed context, the fund's operating partner often makes this decision based on a simple rule: "If the fractional leader has closed more than $2M in pipeline in their first 90 days, hire them full-time; if they have only advised, keep them fractional and evaluate at 6 months."

FAQ

A question? When should a PE-backed company NOT hire a full-time CRO, even if RevOps exists? When the company is below $5M ARR and the founder is still the primary closer, a full-time CRO will consume too much of the budget without adding proportional value - the fund should instead invest in a senior RevOps manager who can systematize the founder's process. Also, if the company is in a "turnaround" situation where the product-market fit is unproven, a full-time CRO cannot fix a broken product, and a fractional leader who can test multiple go-to-market hypotheses is more capital-efficient.

A question? How does the PE fund's hold period affect the CRO hire decision? A fund with a 3-5 year hold period will push for a full-time CRO earlier because they need the revenue acceleration to hit exit multiples, while a fund with a 7+ year hold may tolerate a fractional leader for longer because they have time to build organically. The hold period also dictates the CRO's compensation structure: shorter hold periods favor higher base salary with less equity, while longer holds favor lower base with significant carry or equity to retain the executive through the exit.

A question? What happens if the RevOps leader is promoted to CRO instead of hiring externally? This is risky but can work if the RevOps leader has demonstrated strategic thinking, such as renegotiating a major contract or designing a new pricing model. The fund must provide a 6-month mentorship from an external fractional CRO to bridge the gap, because most RevOps leaders lack the board-level communication skills and the commercial negotiation experience needed to close large deals. If the promoted RevOps leader fails, the fund loses 6-9 months of revenue momentum, so this is only advisable for companies below $10M ARR.

A question? How does the CRO interact with the PE fund's operating partner on a weekly basis? The CRO sends a weekly one-page report every Monday by 9 AM, including pipeline by stage, forecast by rep, closed-won/lost analysis, and any "red flags" that could miss the quarter. The operating partner expects a 30-minute call every Wednesday to review the report and discuss any deals that are at risk, and the CRO must be prepared to defend the forecast with data from RevOps. If the CRO misses two consecutive weekly calls without a valid reason, the fund will escalate to the board and begin a performance improvement plan.

Sources